Nasrin Haghani: Vitamin D and Omega-3 Fatty Acids May Support Mood Regulation
Nasrin Haghani, Surgical Lead Technician at Nuvia Dental Implant Center, shared on LinkedIn:
“Recent research has explored the role of nutrition in mental health, finding that vitamin D and omega-3 fatty acids may significantly support mood regulation. Both nutrients play important biological roles in brain function. Vitamin D influences neurotransmitters such as serotonin, which affects mood stability, while omega-3 fatty acids help maintain the structure of brain cell membranes and support communication between neurons. When levels of these nutrients are low, mood disorders such as depression may become more likely or more severe.
Some clinical studies suggest that supplementation with vitamin D and omega-3s can improve depressive symptoms in certain individuals, particularly those who are deficient. Omega-3 fatty acids, especially EPA and DHA, have been shown to reduce inflammation in the brain, a factor increasingly linked to mood disorders. Vitamin D also supports immune balance and hormonal regulation, which may indirectly influence emotional well-being. These mechanisms help explain why improvements in mood have been observed in some controlled trials when nutritional deficiencies are corrected.
It is important to note that these nutrients are not universal replacements for antidepressant medications, especially in moderate to severe cases. Instead, they may serve as supportive tools within a broader treatment plan that includes professional care, therapy, and healthy lifestyle habits. Balanced nutrition, sunlight exposure, and medical guidance together create a more comprehensive approach to long-term mental health support.”
Stay updated with Hemostasis Today.
-
Mar 31, 2026, 16:05Happy National Doctors’ Day to All Physicians Making a Difference – ASH
-
Mar 31, 2026, 16:03Robert Negrin: Strengthening Collaboration with NCI to Advance Hematology Research
-
Mar 31, 2026, 16:02Jim Hoffman: Does Multiomics Suggest LC PASC Patients Require Multiple Drugs to Correct Biochemical Dysregulation?
-
Mar 31, 2026, 15:59Seema Dawood: Blister Cell in G6PD Deficiency
-
Mar 31, 2026, 15:57Ney Carter Borges: Clopidogrel vs Aspirin in Long-Term Monotherapy
-
Mar 31, 2026, 15:57Join the Webinar on Immunoglobulin Access and Stewardship in the UK and Australia – ISBT
-
Mar 31, 2026, 15:55Hind El Azzazi: Successful Defense of My Medical Doctorate on Antiphospholipid Syndrome in Men
-
Mar 31, 2026, 15:54Rucha Patil: Honored to Speak at AIIMS Nagpur ToT Workshop on Non-Factor Therapy in Hemophilia A
-
Mar 31, 2026, 15:43Deepak Sudheendra: When the Clot Is Gone, but Symptoms Remain